HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn’s Disease Patients

Jean Frédéric Colombel; María D. Martín-Arranz; Brigitta Brinkman; Meijian Guan; Amy Hart; Christopher Gasink

doi:10.1093/ibd/izad273

HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn’s Disease Patients

Jean Frédéric Colombel
, María D. Martín-Arranz
, Brigitta Brinkman
, Meijian Guan
, Amy Hart
, Christopher Gasink

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

It is unknown if inflammatory bowel disease patients carrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to ustekinumab.

Original language	English
Pages (from-to)	2227-2231
Number of pages	5
Journal	Inflammatory Bowel Diseases
Volume	30
Issue number	11
DOIs	https://doi.org/10.1093/ibd/izad273
State	Published - 1 Nov 2024

Keywords

antidrug antibodies
loss of response
ustekinumab

Access to Document

10.1093/ibd/izad273

Cite this

@article{1ab5c278ac1543ddbd335498a1828bd5,

title = "HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn{\textquoteright}s Disease Patients",

abstract = "It is unknown if inflammatory bowel disease patients carrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to ustekinumab.",

keywords = "antidrug antibodies, loss of response, ustekinumab",

author = "Colombel, \{Jean Fr{\'e}d{\'e}ric\} and Mart{\'i}n-Arranz, \{Mar{\'i}a D.\} and Brigitta Brinkman and Meijian Guan and Amy Hart and Christopher Gasink",

year = "2024",

month = nov,

day = "1",

doi = "10.1093/ibd/izad273",

language = "English",

volume = "30",

pages = "2227--2231",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Oxford University Press",

number = "11",

}

TY - JOUR

T1 - HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn’s Disease Patients

AU - Colombel, Jean Frédéric

AU - Martín-Arranz, María D.

AU - Brinkman, Brigitta

AU - Guan, Meijian

AU - Hart, Amy

AU - Gasink, Christopher

PY - 2024/11/1

Y1 - 2024/11/1

N2 - It is unknown if inflammatory bowel disease patients carrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to ustekinumab.

AB - It is unknown if inflammatory bowel disease patients carrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to ustekinumab.

KW - antidrug antibodies

KW - loss of response

KW - ustekinumab

UR - https://www.scopus.com/pages/publications/85208514316

U2 - 10.1093/ibd/izad273

DO - 10.1093/ibd/izad273

M3 - Article

C2 - 38029420

AN - SCOPUS:85208514316

SN - 1078-0998

VL - 30

SP - 2227

EP - 2231

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 11

ER -

HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn’s Disease Patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this